News

Synairgen Announces Positive Results in COVID-19 Clinical Trial

Synairgen Announces Positive Results in COVID-19 Clinical Trial

Synairgen, a respiratory drug discovery and development company, has reported positive results in its COVID-19 clinical trial. Of the participants who received the investigational drug SNG001, 79% had a lower risk of developing severe disease than compared with those that were given a placebo. The trial involved 101 participants and took place in the United Kingdom. With 21 strategically located global depots, including a 7,730 square foot regional depot in Heathrow, London, Yourway has the capacity to service companies in need of clinical trial support around the world.

Back to Index
Media

Upcoming Event

IQPC CTS

August 24-26, 2020
Brussels, Belgium

Media

Articles

The New Normal in Clinical Trial Protection

Open chat
Come chat with us!
Hello! How can I help you?